Your session is about to expire
← Back to Search
Step Tracking for Multiple Sclerosis
N/A
Waitlist Available
Led By Ruchika S Prakash, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months and 6 months
Awards & highlights
Study Summary
This trial will compare the cognitive function of people with relapsing-remitting multiple sclerosis who either do physical activity or drink a lot of water. There will be tests before and after the 6-month period.
Eligible Conditions
- Multiple Sclerosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months and 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Cognitive Performance on a Latent Measure of Working Memory/Processing Speed
Secondary outcome measures
Changes in the Functional Architecture of the MS Brain during Processing Speed
Changes in the Functional Architecture of the MS Brain during Working Memory
Changes on a Self-Report Measure of Anxiety
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Step TrackingExperimental Treatment1 Intervention
Participants will track their physical activity in steps using an accelerometer for a period of 6 months. Participants will monitor their overall step-count using the accelerometer, and daily and weekly summaries of their progress provided by the experimenters.
Group II: Water TrackingActive Control1 Intervention
Participants will track their water-intake using a smart water bottle for a period of 6 months. Participants will monitor their overall water consumption using a smart water bottle, and daily and weekly summaries of their progress provided by the experimenters.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Step Tracking
2017
N/A
~90
Find a Location
Who is running the clinical trial?
National Multiple Sclerosis SocietyOTHER
95 Previous Clinical Trials
9,396 Total Patients Enrolled
93 Trials studying Multiple Sclerosis
9,042 Patients Enrolled for Multiple Sclerosis
Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
505,656 Total Patients Enrolled
4 Trials studying Multiple Sclerosis
281 Patients Enrolled for Multiple Sclerosis
Ruchika S Prakash, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
62 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
62 Patients Enrolled for Multiple Sclerosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger